SREBPs are transcriptional activators central to cholesterol homeostasis. Recent work has shown that a two-step cleavage of membrane-bound SREBPs frees them to enter the nucleus. An activator of the first, sterol-regulated proteolysis step has also been identified.
The metabolism of cholesterol is highly regulated and of great medical importance. A diet high in fat leads to high levels of cholesterol in liver cells, repressing the synthesis of receptors for low density lipoprotein (LDL), a cholesterol-carrying plasma protein, and so raising the concentration of cholesterol in the bloodstream. One way in which the over-accumulation of cholesterol is prevented is the sterol-regulated degradation of the rate-controlling enzyme of cholesterol biosynthesis, 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase [1] . But of equal importance here is the regulation of the two sterol regulatory element binding proteins (SREBPs). Recent exciting results have shown that an intricate two-step proteolytic pathway ensures that SREBPs, which are ordinarily docked at the membrane, are targeted to the nucleus only when sterol accumulation is needed [2, 3] .
The SREBPs were first purified as a mixture of ∼65 kDa proteins that bound to the cis-acting sterol regulatory element (SRE) in the promoter of the human LDL receptor gene (discussed in [2, 3] and references therein). The two cDNAs that were isolated are predicted to encode highly related products of ∼125 kDa ( [4] and references therein). Although the need for two SREBPs is still largely a mystery, evidence from animal feeding experiments indicates that SREBP-1 and SREBP-2 are differentially regulated by dietary perturbation of cholesterol metabolism [5] . The size difference between the isolated proteins and the predicted gene products immediately begs the question of how the ∼65 kDa species are related to the larger products. The substantial new information that addresses this question directly links SREBP processing to cholesterol homeostasis.
The first important observation was that SREBPs are anchored in a hairpin fashion to the endoplasmic reticulum (ER) membrane as 125 kDa species (Fig. 1) . The amino terminus of each SREBP is in the cytosol, and includes an acidic transcriptional activation domain linked to a DNA-binding domain with a basic helix-loop-helix and a leucine zipper. The two membrane-spanning helices that follow are separated by a short loop in the ER lumen, and the carboxyl terminus is found in the cytosol.
Upon sterol depletion, the amount of membrane-attached 125 kDa material decreases and the ∼65 kDa material accumulates in the nucleus ( [6] and references therein). This is consistent with a precursor-product relationship between the two species, and indeed the amino-terminal Structure and regulation of SREBPs. When sterols are present, SREBPs are localized to the membrane, probably in the ER. Low levels of sterols trigger the SCAP-dependent cleavage of SREBPs at site 1. This leads directly to cleavage at site 2, which is dependent on the target sequence Asp-Arg-Ser-Arg, or DRSR in the one-letter amino acid code, and release of the amino-terminal domain, which is now free to enter the nucleus. The SREBPs then bind the SREs in the promoters of many genes, including those for HMG CoA synthase and the LDL receptor, and activate their transcription; the SREBPs bind to the SREs via their basic helix-loop-helix and leucine zipper (bHLH/LZ) domain. segment is released from the membrane by proteolysis before entering the nucleus and activating transcription of genes that include those encoding HMG CoA synthase and the LDL receptor. High levels of cholesterol reduce the amount of cleavage of the membrane-bound SREBPs, but increase the degradation of nuclear SREBPs. More recently, the details of the cleavage process have been elucidated. SREBPs are released from the membrane through two sequential proteolytic steps [2, 3] . The first cleavage (at site 1 in Fig. 1 ) occurs only when sterol levels fall. Cleavage at site 2 then proceeds rapidly but is critically dependent on prior cleavage at site 1 [3] . This second cleavage occurs at residues that are usually in the middle of the membrane-spanning segment, as does the cleavage of amyloid precursor protein when amyloid ␤ protein is formed in Alzheimer's disease.
Thus, two key cholesterol regulatory proteins are resident ER membrane proteins and are themselves regulated by proteolysis. High sterol levels cause the degradation of HMG CoA reductase and repress the release, and therefore activity, of SREBPs. The challenge now is to determine exactly what the sensing mechanisms are that trigger SREBP processing and HMG CoA reductase degradation, whether they are similar or related, and how sterol sensing is tied to proteolysis.
A step in this direction was made recently with the identification of an SREBP cleavage activating protein (SCAP) [7] . The cells used in this study were from a dominant oxysterol-resistant line of cultured CHO cells. Oxysterols are efficient regulators of intracellular cholesterol metabolism, but fail to substitute for cholesterol in cellular membranes. Thus, when cells are supplied with oxysterol but starved for cholesterol, they die unless they are insensitive to the regulatory effects of oxysterols. Resistant cells isolated in this way were used as the source of a cDNA library, which was used to transfect cells with a luciferase reporter controlled by tandem SREs. The presence of a cDNA for a hyperactive SCAP from this library prevented sterol repression of luciferase expression. When expressed ectopically, the mutant SCAP stimulated cleavage of SREBPs more avidly than wild-type SCAP at the correct lumenal site 1 (Fig. 1) . Once this initial clip has occurred, the second cleavage follows rapidly and the unencumbered SREBPs enter the nucleus and activate gene expression. Apparently, the highly active mutant SCAP activates SREBP cleavage and cholesterol synthesis even in the presence of high concentrations of oxysterols that would inhibit wild-type SCAP and hence kill normal cells.
The increased activity of the mutant SCAP results from a missense mutation that changes an aspartate to an asparagine in a predicted membrane domain. Analysis of the coding sequence suggested SCAP contains multiple membrane spans, and indeed wild-type SCAP was membrane-localized. Surprisingly, the predicted membrane domains of SCAP displayed striking similarity (55%) to the membrane domain of HMG CoA reductase. This similarity may reflect the fact that both regions are sterol sensors, as this region of HMG CoA reductase must be intact for accelerated degradation of reductase enzyme in the presence of high sterol concentrations [1] . This would, in turn, suggest that the ER membrane may be directly involved in sterol sensing.
The only other clue revealed by sequence comparisons was the presence of several tryptophan-aspartate (WD) repeats in SCAP. In other proteins containing WD repeats -none of which are enzymes -the repeats are known to be involved in protein-protein interactions. This evidence, and the fact that SCAP does not share similarity to known proteases, suggests that SCAP probably functions by interacting with another protein, perhaps SREBPs, or the elusive SREBP protease, or both.
SCAP
has not yet been localized to a particular membrane but, given that it functions in SREBP processing and has similarity to HMG CoA reductase, it is probably an ER protein.
The concentration of cholesterol in the ER membrane is relatively low and minimal changes in that concentration, in either direction, could significantly alter basic membrane properties, such as fluidity and width. It is possible that SCAP senses the concentration of cholesterol in the ER membrane and, if the concentration is below a threshold level, initiates a signaling process culminating in activation of the site 1 protease. A more thorough understanding of how SCAP functions in sterol regulation should be forthcoming from structure-function studies in cultured cells and gene-targeting experiments in animals.
Membrane-bound SREBPs may be proteolytically activated by signals other than low levels of intracellular sterols. SREBPs are involved in the regulation of fatty acid biosynthesis and SREBP-1 is activated, perhaps to stimulate fatty acid biosynthesis, during differentiation of preadipocytic cells into fat-laden adipocytes in culture ( [8] and references therein). The exact mechanism of activation and whether different SREBPs are preferentially activated by distinct signals remain to be determined.
SREBP-1 and SREBP-2 are in vitro substrates for CPP32/SCA-I and Mch3/SCA-2, homologs of proteases known to be activated during early stages of programmed cell death ( [9] and references therein). This cleavage occurs at a site distinct from that recognized by the sterolsensing pathway but, as in the sterol-regulated pathway, the product is predicted to be soluble and targeted to the nucleus. Consistent with these in vitro data, SREBP-1 and SREBP-2 were activated by apoptotic signaling through cleavage at the predicted site in cultured cells. Thus, SREBPs are activated through at least one other distinct signaling process, although the role, if any, for SREBPs during programmed cell death remains obscure.
The findings discussed above represent important new advances in our understanding of sterol regulation. Two other noteworthy advances concerning cholesterol were reported recently. The first documented that oxysterols directly activate a novel ligand-activated nuclear receptor called LXR [10] . The oxysterol activators of LXR are intermediates in both steroid hormone and bile acid biosynthetic pathways. It is therefore tempting to speculate that LXR activates genes required to convert these oxysterols efficiently into steroids and bile acids only when sufficient intermediates are available. LXR appears to function as a heterodimer along with the retinoid X receptor (RXR), and the heterodimer is also activated by certain retinoids. As for many nuclear receptors, the details of ligand-specific responses are not yet known.
The other new finding documents a novel function for cholesterol during development. Sonic hedgehog (Shh) protein, which is involved in intercellular signaling during early embryonic pattern formation, is known to be lipidmodified. In the new work, it was suggested that the A ring hydroxyl group of the sterol nucleus participates as a nucleophile in the auto-proteolytic processing of Shh protein [11] . This reaction results in the attachment of cholesterol to the carboxyl terminus of the active aminoterminal domain, which should decrease the rate of diffusion of the Shh domain in the extracellular space and thus restrict the range of action for mature, secreted Shh protein. This establishes a previously unrecognized and essential role for cholesterol.
Thus, significant and surprising findings related to cholesterol and its metabolism surfaced during the past year, and a strong argument could be made that cholesterol truly was the 'molecule of the year' for 1996.
